(Q43957591)

28 November 2017

title

Diagnostic potential of serum direct markers and non-invasive fibrosis models in patients with chronic hepatitis B. (English)

1 reference

28 November 2017

Ozge Gümüşay

1

1 reference

28 November 2017

Seren Ozenirler

2

1 reference

28 November 2017

Ayşegül Atak

3

1 reference

28 November 2017

Cemile Sönmez

4

1 reference

28 November 2017

Seçil Ozkan

5

1 reference

28 November 2017

Ayşe Fıtnat Tuncel

6

1 reference

28 November 2017

Güldal Yılmaz

7

1 reference

28 November 2017

Gülen Akyol

8

1 reference

28 November 2017

language of work or name

1 reference

26 June 2012

1 reference

28 November 2017

1 reference

28 November 2017

volume

43

1 reference

28 November 2017

issue

3

1 reference

28 November 2017

page(s)

228-237

1 reference

Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01057.X

Baseline predictors of virological response for chronic hepatitis B patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01057.X

Molecular characteristics and stages of chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01057.X

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01057.X

Liver fibrosis and chronic viral hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01057.X

Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01057.X

Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01057.X

Sampling variability of liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01057.X

Serum markers detect the presence of liver fibrosis: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01057.X

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01057.X

Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01057.X

Comparison of surrogate serum markers and transient elastography (Fibroscan) for assessing cirrhosis in patients with chronic viral hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01057.X

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01057.X

Serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: effect of alpha-interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01057.X

Connective tissue polypeptides in serum as parameters to monitor antifibrotic treatment in hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01057.X

Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01057.X

Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01057.X

Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01057.X

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01057.X

Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01057.X

Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01057.X

Combining non-invasive methods for assessment of liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01057.X

SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01057.X

Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2012.01057.X

10.1111/J.1872-034X.2012.01057.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference